cancer-related fatigue
Conditions
Interventions
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with stage IV lung cancer diagnosed by pathology; 2) Patients requiring chemotherapy; 3) Patients receiving platinum-containing two-drug regimens chemotherapy and is expected to receive four more cycles of regimens chemotherapy in the future; 4) The scores of tumor patients on the subjective fatigue level screening scale were >= 4 points; 5) Normal cognitive function and able to independently complete the questionnaire related to the research; 6) Hematology, liver and kidney functions and important organ functions meet the requirements of chemotherapy; 7) No obvious obstacle in swallowing function, able to take the study drugs orally smoothly; 8) Informed and consented to participate in the clinical trial, and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients have other exact causes of fatigue (such as hypothyroidism, insomnia, uncontrolled pain, moderate to very severe anemia, severe malnutrition, cachexia, etc.); 2) Patients who have been using or are allergic to renal qi GUI, or have a history of drug-induced liver injury. 3) Patients are already taking prescription stimulants or other drugs/health care products with clearly marked anti-fatigue effects; 4) Patients with other types of cancer and tumor stage other than stage IV; 5) Complicated mental disorders (anxiety, bipolar disorder, obsessive-compulsive disorder, schizophrenia), acute or chronic progressive or unstable neurological states (dementia, delirium, or epilepsy); Cognitive dysfunction; 6) Other diseases requiring treatment with glucocorticoids (excluding chemotherapy pretreatment); 7) Patients with poor compliance and are not expected to complete the study as planned; 8) Pregnant or lactating women; 9) Patients with hypertensive crisis, diabetic ketoacidosis, serious liver diseases such as decompensation of cirrhosis and severe renal insufficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Piper fatigue scale; | — |
Countries
China
Contacts
Public ContactWeigang Xiu
West China Hospital of Sichuan University
Outcome results
None listed